Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-09

Clinical Trial Update: Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigates the dose-dependent effect of rosuvastatin on long-term clinical outcomes after percutaneous coronary intervention in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Coronary Artery Disease, Coronary Disease | Phase 4 | Status: UNKNOWN